These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31801863)

  • 1. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
    Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
    Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
    J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
    Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.
    Lai IY; Farrell PJ; Kellam P
    J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions.
    Dalton-Griffin L; Wilson SJ; Kellam P
    J Virol; 2009 Jul; 83(14):7202-9. PubMed ID: 19403667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
    Deng H; Song MJ; Chu JT; Sun R
    J Virol; 2002 Aug; 76(16):8252-64. PubMed ID: 12134031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus.
    Yamaguchi T; Watanabe T; Iwaisako Y; Fujimuro M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Gutierrez IV; Dayton J; Harger S; Rossetto CC
    J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
    Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
    Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
    Rivera-Soto R; Dissinger NJ; Damania B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
    Naimo E; Zischke J; Schulz TF
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.
    Pantry SN; Medveczky PG
    Semin Cancer Biol; 2009 Jun; 19(3):153-7. PubMed ID: 19429478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
    Sakakibara S; Tosato G
    J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.